Signaling pathways involved in osteogenesis and their application for bone regenerative medicine

Tissue Engineering - Part B: Reviews

Volumn 21, Issue 1, 2015, Pages 75-87

  Hayrapetyan, Astghik ^a   Jansen, John A ^a   Van Den Beucken, Jeroen J J P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL SIGNALING; FLOWCHARTING; MACHINERY; REGENERATIVE MEDICINE; SIGNALING; STEM CELLS; TISSUE REGENERATION;

BONE SUBSTITUTE MATERIALS; INTRACELLULAR NETWORKS; MESENCHYMAL STEM CELL; MOLECULAR MACHINERY; OSTEOGENIC POTENTIAL; PHYSIOLOGICAL PROCESS; SIGNALING MECHANISMS; SIGNALING MOLECULES;

BONE;

BONE MORPHOGENETIC PROTEIN; CALCIUM ION; FIBROBLAST GROWTH FACTOR; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR;

ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CALCIUM SIGNALING; CELL COMMUNICATION; CELL INTERACTION; DEGRADATION; HUMAN; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SURFACE PROPERTY; WNT SIGNALING PATHWAY; ANIMAL; CYTOLOGY; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; BONE REGENERATION; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84922715139     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2014.0119     Document Type: Article

References (114)

1. Reddi, A.H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16, 247, 1998.
2. Fisher, J.P., and Reddi, A.H. Functional tissue engineering of bone: signals and scaffolds. In: Ashammakhi, N., and Ferretti, P., eds. Topics in Tissue Engineering. Oulu, Finland: EXPERTISSUES e-book, 2003, pp.1-29.
3. Boyle, W.J., Simonet, W.S., and Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337, 2003.
4. McLean, R.R., Jacques, P.F., Selhub, J., Tucker, K.L., Samelson, E.J., Broe, K.E., et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350, 2042, 2004.
5. Hyun, J.S., Nelson, E.R., Montoro, D., Levi, B., and Longaker, M.T. Skeletal and adipose tissue engineering with adipose-derived stromal cells. In: Eberli, D., ed. Intech. Tissue Engineering for Tissue and Organ Regeneration. Rijeka, Croatia, 2011, pp. 107-128.
6. Clohisy, D.R., and Mankin, H.J. Osteoarticular allografts for reconstruction after resection of a musculoskeletal tumor in the proximal end of the tibia. J Bone Joint Surg Am 76, 549, 1994.
7. Gom'ez-Barrena, E., Rosset, P., Müller, I., Giordano, R., Bunu, C., Layrolle, P., et al. Bone regeneration: stromal cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med 15, 1266, 2011.
8. Barrère, F., Van Blitterswijk, C.A., and De Groot, K. Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomed 1, 317, 2006.
9. ͆lósarczyk, A., Paszkiewicz, Z., and Paluszkiewicz, C. FTIR and XRD evaluation of carbonated hydroxyapatite powders synthesized by wet methods. J Mol Struct 744, 657, 2005.
10. Dimitriou, R., Jones, E., McGonagle, D., and Giannoudis, P.V. Bone regeneration: current concepts and future directions. BMC Med 9, 66, 2011.
11. Kempen, D.H., Creemers, L.B., Alblas, J., Lu, L., Verbout, A.J., Yaszemski, M.J., et al. Growth factor interactions in bone regeneration. Tissue Eng Part B Rev 16, 551, 2010.
12. Cai, X., Su, X., Li, G., Wang, J., and Lin, Y. Osteogenesis of adipose-derived stem cells. In: Lin, Y. ed. Osteogenesis, Rijeka, Croatia: Intech, 2012, pp. 135-152.
13. Orbay, H., Tobita, M., and Mizuno, H. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int 2012, 461, 2012.
14. Lee, R.H., Kim, B., Choi, I., Kim, H., Choi, H., Suh, K., et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14, 311, 2004.
15. Tapp, H., Hanley, E.N., Patt, J.C., and Gruber, H.E. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med 234, 1, 2009.
16. Sousa, B.R., Parreira, R.C., Fonseca, E.A., Amaya, M.J., Tonelli, F.M., Lacerda, S., Lalwani, P., Santos, A.K., Gomes, K.N., and Ulrich, H. Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry Part A 85, 43, 2013.
17. Ohishi, M., and Schipani, E. Bone marrow mesenchymal stem cells. J Cell Biochem 109, 277, 2010.
18. Anam, K., and Davis, T.A. Comparative analysis of gene transcripts for cell signaling receptors in bone marrowderived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations. Stem Cell Res Ther 4, 1, 2013.
19. Tobita, M., Orbay, H., and Mizuno, H. Adipose-derived stem cells: current findings and future perspectives. Discov Med 11, 160, 2011.
20. Zhang, Y., Khan, D., Delling, J., and Tobiasch, E. Mechanisms underlying the osteo-and adipo-differentiation of human mesenchymal stem cells. Sci World J 2012, 793, 2012.
21. Szpalski, C., Barbaro, M., Sagebin, F., and Warren, S.M. Bone tissue engineering: current strategies and techniques-part ii: cell types. Tissue Eng Part B Rev 18, 258, 2012.
22. Marks, F., Klingmüller, U., and Müller-Decker, K. Signal transduction by Serine/Threonine Kinase-Coupled Receptros. In: Foltin, J. ed. Cellular Signal Processing: An Introduction to the Molecular Mechanisms of Signal Transduction. New York, NY: Garland Science, 2009, pp. 219-239.
23. Herford, A.S., Stoffella, E., and Tandon, R. Reconstruction of mandibular defects using bone morphogenic protein: can growth factors replace the need for autologous bone grafts? a systematic review of the literature. Plast Surg Int 2011, 165, 2011.
24. Chen, G., Deng, C., and Li, Y.P. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8, 272, 2012.
25. Arvidson, K., Abdallah, B., Applegate, L., Baldini, N., Cenni, E., Gomez-Barrena, E., Granchi, D., Kassem, M., Konttinen, Y.T., Mustafa, K., Pioletti, D.P., Sillat, T., and Finne-Wistrand, A. Bone regeneration and stem cells. J Cell Mol Med 15, 718, 2011.
26. 2+ signaling during osteoclast differentiation. IBMS Bone-KEy 6, 301, 2009.
27. Tomomura, M., Hasegawa, H., Suda, N., Sakagami, H., and Tomomura, A. Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-kB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway. J Biol Chem 287, 17963, 2012.
28. Li, H., Xu, D., Toh, B.H., and Liu, J.P. TGF-β and cancer: is Smad3 a repressor of hTERT gene. Cell Res 16, 169, 2006.
29. Massagué, J., and Wotton, D. NEW EMBO MEMBER'S REVIEW: transcriptional control by the TGF-β/Smad signaling system. EMBO J 19, 1745, 2000.
30. Guo, X., and Wang, X.F. Signaling cross-talk between TGF-β and BMP and other pathways. Cell Res 19, 71, 2008.
31. Ehrlich, M., Gutman, O., Knaus, P., and Henis, Y.I. Oligomeric interactions of TGF-β and BMP receptors. FEBS Lett 586, 1885, 2012.
32. Miyazono, K., Kamiya, Y., and Morikawa, M. Bone morphogenetic protein receptors and signal transduction. J Biochem 147, 35, 2010.
33. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-b receptor. Nature 370, 341, 1994.
34. Hill, C.S. Nucleocytoplasmic shuttling of Smad proteins. Cell Res 19, 36, 2008.
35. Ross, S., and Hill, C.S. How the Smads regulate transcription. Int J Biochem Cell Biol 40, 383, 2008.
36. Matsunobu, T., Torigoe, K., Ishikawa, M., de Vega, S., Kulkarni, A.B., Iwamoto, Y., et al. Critical roles of the TGF-β type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol 332, 325, 2009.
37. Schaeffer, H.J., and Weber, M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19, 2435, 1999.
38. Wagner, E.F., and Nebreda, Á.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9, 537, 2009.
39. Liedert, A., Kaspar, D., Blakytny, R., Claes, L., and Ignatius, A. Signal transduction pathways involved in mechanotransduction in bone cells. Biochem Biophys Res Commun 349, 1, 2006.
40. Iqbal, J., and Zaidi, M. Molecular regulation of mechanotransduction. Biochem Biophys Res Commun 328, 751, 2005.
41. Mikuni-Takagaki, Y. Mechanical responses and signal transduction pathways in stretched osteocytes. J Bone Miner Metab 17, 57, 1999.
42. Hughes-Fulford, M. Signal transduction and mechanical stress. Sci Signal 2004, 12, 2004.
43. 2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells. Cell Signal 20, 613, 2008.
44. Khoshniat, S., Bourgine, A., Julien, M., Petit, M., Pilet, P., Rouillon, T., Masson, M., Gatius, M., Weiss, P., Guicheux, J., and Beck, L. Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/ 2 pathway is modulated by calcium. Bone 48, 894, 2011.
45. Hoodless, P.A., Haerry, T., Abdollah, S., Stapleton, M., O'Connor, M.B., Attisano, L., and Wrana, J.L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489, 1996.
46. Barradas, A., Fernandes, H.A.M., Groen, N., Chai, Y.C., Schrooten, J., van de Peppel, J., van Leeuwen, J.P., van Blitterwijk, C.A., and de Boer, J. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials 33, 3025, 2012.
47. Helm, G.A., Sheehan, J.M., Sheehan, J.P., Jane, J.A., Jr, diPierro, C.G., Simmons, N.E., Gillies, G.T., Kallmes, D.F., and Sweeney, T.M. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 86, 93, 1997.
48. Yang, S., Tian, Y.S., Lee, Y.J., Yu, F.H., and Kim, H.M. Mechanisms by which the inhibition of specific intracellular signaling pathways increase osteoblast proliferation on apatite surfaces. Biomaterials 32, 2851, 2011.
49. Harada, S., and Rodan, G.A. Control of osteoblast function and regulation of bone mass. Nature 423, 349, 2003.
50. Westendorf, J.J., Kahler, R.A., and Schroeder, T.M. Wnt signaling in osteoblasts and bone diseases. Gene 341, 19, 2004.
51. Huang, W., Yang, S., Shao, J., and Li, Y.P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12, 92, 2007.
52. Habas, R., and Dawid, I.B. Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol 4, 2, 2005.
53. Habas, R., Dawid, I.B., and He, X. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev 17, 295, 2003.
54. Yun, Y-R., Won, J.E., Jeon, E., Lee, S., Kang, W., Jo, H., et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 1, 218142, 2010.
55. Ornitz, D.M., and Marie, P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16, 1446, 2002.
56. Coutu, D.L., and Galipeau, J. Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY) 3, 920, 2011.
57. Xiao, G., Jiang, D., Gopalakrishnan, R., and Franceschi, R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277, 36181, 2002.
58. Naski, M.C., and Ornitz, D.M. FGF signaling in skeletal development. Fetal Pediatr Pathol 18, 355, 1998.
59. Jacob, A.L., Smith, C., Partanen, J., and Ornitz, D.M. Fibroblast growth factor receptor 1 signaling in the osteochondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296, 315, 2006.
60. Koch, H., Jadlowiec, J.A., and Campbell, P.G. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14, 621, 2005.
61. Kimura, T., Kuwata, T., Ashimine, S., Yamazaki, M., Yamauchi, C., Nagai, K., et al. Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment. Clin Cancer Res 16, 121, 2010.
62. Kratchmarova, I., Blagoev, B., Haack-Sorensen, M., Kassem, M., and Mann, M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Sci Signal 308, 1472, 2005.
63. Tokunaga, A., Oya, T., Ishii, Y., Motomura, H., Nakamura, C., Ishizawa, S., Fujimori t, Nabeshima, Y., Umezawa, A., Kanamori, M., Kimura, T., and Sasahara, M. PDGF receptor bβ is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res 23, 1519, 2008.
64. Kumar, A., Salimath, B.P., Stark, G.B., and Finkenzeller, G. Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A 16, 983, 2010.
65. Sethi, N., and Kang, Y. Notch signaling: mediator and therapeutic target of bone metastasis. BoneKEy Rep 3, 1038, 2012.
66. Franceschi, R.T., and Xiao, G. Regulation of the osteoblastspecific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88, 446, 2002.
67. Liu, T.M., and Lee, E.H. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev 19, 254, 2012.
68. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
69. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., BronsonRT, Gao, Y.H., Inada, M., Sato, M., Okamoto, R., KitamuraY, Yoshiki, S., and Kishimoto, T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755, 1997.
70. Banerjee, C., McCabe, L.R., Choi, J.Y., Hiebert, S.W., Stein, J.L., Stein, G.S., Lian, J.B. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66, 1, 1997.
71. Kanno, T., Takahashi, T., Tsujisawa, T., Ariyoshi, W., and Nishihara, T. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J Cell Biochem 101, 1266, 2007.
72. D'Souza, R.N., Aberg, T., Gaikwad, J., Cavender, A., Owen, M., Karsenty, G., et al. Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice. Development 126, 2911, 1999.
73. Jun, J.H., Yoon, W.J., Seo, S.B., Woo, K.M., Kim, G.S., Ryoo, H.M., and Beak, J.H. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem 285, 36410, 2010.
74. Zhang, X., Yang, M., Lin, L., Chen, P., Ma, K., Zhou, C., and Ao, Y.F. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif Tissue Int 79, 169, 2006.
75. Bishop, G.B., and Einhorn, T.A. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31, 721, 2007.
76. Carragee, E.J., Hurwitz, E.L., and Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11, 471, 2011.
77. Tsuda, H., Wada, T., Ito, Y., Uchida, H., Dehari, H., Nakamura, K., Sasaki, K., Kobune, M., Yamashita, T., and Hamada, H. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 7, 354, 2003.
78. Jullien, N., Maudinet, A., Leloutre, B., Ringe, J., Häupl, T., and Marie, P.J. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells. J Cell Biochem 113, 2047, 2012.
79. Schindeler A. Preclinical studies in orthopedics and bone repair. IBMS BoneKEy 9, 1038, 2012.
80. Ma, J., Both, S.K., Yang, F., Cui, F-Z., Pan, J., Meijer, G.J., Jansen, J.A., and Beucken, J.J. Concise review: cellbased strategies in bone tissue engineering and regenerative medicine. Stem Cells Transl Med 3, 98, 2014.
81. Matsubara, H., Hogan, D.E., Morgan, E.F., Mortlock, D.P., Einhorn, T.A., and Gerstenfeld, L.C. Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis. Bone 51, 168, 2012.
82. Grellier, M., Bordenave, L., and Amedee, J. Cell-tocell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27, 562, 2009.
83. Tsuji, K., Bandyopadhyay, A., Harfe, B.D., Cox, K., Kakar, S., Gerstenfeld, L., Einhorn, T., Tabin, C.J., and Rosen, V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38, 1424, 2006.
84. Henrich, D., Wilhelm, K., Warzecha, J., Frank, J., Barker, J., Marzi, I., and Seebach, C. Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone. Mediat Inflamm 2013, 364, 2013.
85. Ma, J., Beucken, J.J., Both, S.K., Prins, H.J., Helder, M.N., Yang, F., and Jansen, J.A. Osteogenic capacity of human BM-MSCs, AT-MSCs and their co-cultures using HUVECs in FBS and PL supplemented media. J Tissue Eng Regen Med 1002, 1704, 2013.
86. Ma, J., Both, S.K., Ji, W., Yang, F., Prins, H.J., Helder, M.N., Pan, J., Cui, F.Z., Jansen, J.A., and Beuken, J.J. Adipose tissue-derived mesenchymal stem cells as monocultures or cocultures with human umbilical vein endothelial cells: performance in vitro and in rat cranial defects. J Biomed Mater Res Part A 1002, 34775, 2013.
87. Heinemann, C., Heinemann, S., Worch, H., and Hanke, T. Development of an osteoblast/osteoclast coculture derived by human bone marrow stromal cells and human monocytes for biomaterials testing. Eur Cell Mater 21, 80, 2011.
88. Ekström, K., Omar, O., Grané li, C., Wang, X., Vazirisani, F., and Thomsen, P. Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells. PloS One 8, 75227, 2013.
89. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: state of the art and future trends. Macromol Biosci 4, 743, 2004.
90. Freed, L.E., and Vunjak-Novakovic, G. Culture of organized cell communities. Adv Drug Deliv Rev 33, 15, 1998.
91. Chai, C., and Leong, K.W. Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther 15, 467, 2007.
92. Marletta, G., Ciapetti, G., Satriano, C., Perut, F., Salerno, M., and Baldini, N. Improved osteogenic differentiation of human marrow stromal cells cultured on ion-induced chemically structured poly-epsion-caprolactone. Biomaterials 28, 1132, 2007.
93. Nair, M.B., Varma, H., and John, A. Platelet-Rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrow-derived stem cells. Tissue Eng Part A 15, 1619, 2008.
94. Martin, J., Schwartz, Z., Hummert, T., Schraub, D., Simpson, J., Lankford, J., Dean, D.D., Cochran, D.L., BoyanBD. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 29, 389, 1995.
95. Lincks, J., Boyan, B., Blanchard, C., Lohmann, C., Liu, Y., Cochran, D., Dean, D.D., and Schwartz, Z. Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 19, 2219, 1998.
96. Gallagher, W.M., Lynch, I., Allen, L.T., Miller, I., Penney, S.C., O'Connor, D.P., Penningen, S., Keenen, A.K., and Dawson, K.A. Molecular basis of cell-biomaterial interaction: insights gained from transcriptomic and proteomic studies. Biomaterials 27, 5871, 2006.
97. Mamails, A., and Silvestors, S. Modified titanium surfaces alter osteogenic differentiation; a comparative microarraybased analysis of human mesenchymal cell response to commercial titanium surfaces. J Oral Implantol 39, 591, 2011.
98. Boyan, B., Bonewald, L., Paschalis, E., Lohmann, C., Rosser, J., Cochran, D., et al. Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography. Calcif Tissue Int 71, 519, 2002.
99. Le Gué hennec, L., Soueidan, A., Layrolle, P., and Amouriq, Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater 23, 844, 2007.
100. Unadkat, H.V., Hulsman, M., Cornelissen, K., Papenburg, B.J., Truckenmüller, R.K., Carpenter, A.E., Wessling, M., Post, G.F., Uetz, M., Reinders, M.J., Stamatialis, D., Van Blitterswijk, C.A., and de Boer J. An algorithm-based topographical biomaterials library to instruct cell fate. Proc Natl Acad Sci U S A 108, 16565, 2011.
101. LeGeros, R.Z. Calcium phosphate-based osteoinductive materials. Chem Rev 108, 4742, 2008.
102. Daculsi, G., Laboux, O., Malard, O., and Weiss, P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med 14, 195, 2003.
103. Wang, C., Lin, K., Chang, J., and Sun, J. Osteogenesis and angiogenesis induced by porous b-CaSiO3/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways. Biomaterials 34, 64, 2012.
104. Kotzsch, A., Nickel, J., Seher, A., Heinecke, K., van Geersdaele, L., Herrmann, T., Sebald, W., and Mueller, T.D. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome. J Biol Chem 283, 5876, 2008.
105. Bragdon, B., Bonor, J., Shultz, K.L., Beamer, W.G., Rosen, C.J., and Nohe, A. Bone morphogenetic protein receptor type Ia localization causes increased BMP2 signaling in mice exhibiting increased peak bone mass phenotype. J Cell Physiol 227, 2870, 2012.
106. Massagué, J., and Chen, Y.G. Controlling TGF-beta signaling. Sci Signal 14, 627, 2000.
107. Lee, K.S., Hong, S.H., and Bae, S.C. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21, 7156, 2002.
108. Franceschi, R.T., Xiao, G., Jiang, D., Gopalakrishnan, R., Yang, S., and Reith, E. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 44, 109, 2003.
109. Major, M.L., Cheung, H.S., and Misra, R.P. Basic calcium phosphate crystals activate c- fosexpression through a Ras/ERK dependent signaling mechanism. Biochem Biophys Res Commun 355, 654, 2007.
110. Ma, S., Yang, Y., Carnes, D., Kim, K., Park, S., Oh, S.H., and Ong, J.L. Effects of dissolved calcium and phosphorous on osteoblast responses. J Oral Implantol 31, 61, 2005.
111. Stolberg, S.G. The biotech death of Jesse Gelsinger. New York Times Magazine 28, 136, 1999.
112. Hollinger, J.O., Hart, C.E., Hirsch, S.N., Lynch, S., and Friedlaender, G.E. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg 48, 90, 2008.
113. Kaigler, D., Avila, G., Wisner-Lynch, L., Nevins, M.L., Nevins, M., Rasperini, G., Lynch, S.E., and Giannobile, W.V. Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Exp Opin Biol Ther 375, 11, 2011.
114. Hilton, M.J., Tu, X., Wu, X., Bai, S., Zhao, H., Kobayashi, T., Kronenberg, H.M., Teitelbaum, S.L., F.P. Ross, and R. Kopan, Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 306, 14, 2008.